Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Janssen
Janssen
Janssen combines Darzalex with COVID-19 drug in new multiple myeloma submission
Pharmaforum
Fri, 11/13/20 - 12:11 pm
Janssen
Multiple Myeloma
Darzalex
EMA
FDA
Johnson & Johnson readies to resume COVID-19 vaccine trial in the US
Biopharma Reporter
Mon, 10/26/20 - 11:03 am
J&J
COVID-19
vaccines
Janssen
Janssen’s Simponi Aria Gains Extended FDA Approvals for Rare Children’s Arthritis Conditions
Xtalks
Tue, 10/6/20 - 11:19 pm
Janssen
JNJ
Simponi Aria
polyarticular juvenile idiopathic arthritis
FDA
Michigan’s GRAM Inks COVID-19 Vaccine Manufacturing Deal with J&J
BioSpace
Tue, 09/29/20 - 11:59 am
GRAM
Janssen
JNJ
drug manufacturing
vaccines
COVID-19
CDMOs
Genmab and Janssen Head to Arbitration Table Over Darzalex Royalties
BioSpace
Wed, 09/23/20 - 10:22 am
Genmab
JNJ
Janssen
Darzalex
arbitration
Multiple Myeloma
Janssen files Darzalex Faspro for rare disease light chain amyloidosis
Pharmaforum
Sat, 09/12/20 - 10:16 pm
JNJ
Janssen
Darzalex Faspro
light chain amyloidosis
Janssen gets expanded EC nod for blood cancer combo drug Imbruvica plus rituximab
Pharmaceutical Business Review
Tue, 09/8/20 - 10:41 am
JNJ
Janssen
Europe
Imbruvica
rituximab
CLL
J&J to start mid-stage coronavirus vaccine trials in three European countries
Reuters
Fri, 08/28/20 - 10:55 am
JNJ
Janssen
vaccines
COVID-19
clinical trials
Europe
Spain
The Netherlands
Germany
Five Top Drugmakers Reveal List vs. Net Price Gaps
Drug Channels
Tue, 08/11/20 - 01:17 pm
Eli Lilly
Janssen
Merck
Novartis
Sanofi
drug pricing
Janssen’s Tremfya gets FDA approval for active psoriatic arthritis
Pharmaceutical Business Review
Wed, 07/15/20 - 10:20 am
Janssen
JNJ
FDA
Tremfya
psoriatic arthritis
Rebooting the healthcare system post-COVID-19
Pharmaforum
Mon, 07/13/20 - 11:30 pm
Janssen
Healthcare
pharma industry
pandemic
COVID-19
innovation
patients
technology
J&J’s Ebola vaccine approved in EU
Pharmaforum
Fri, 07/3/20 - 01:07 pm
Europe
JNJ
ebola virus
Janssen
vaccines
Bavarian Nordic
J&J scraps late-stage study testing Stelara for lupus
Reuters
Sat, 06/27/20 - 11:40 pm
JNJ
Janssen
lupus
Stelara
clinical trials
J&J brings forward start of COVID-19 vaccine trial to next month
Pharmaforum
Wed, 06/10/20 - 11:51 pm
JNJ
vaccines
Janssen
COVID-19
Ad26.COV2-S
Janssen Presents First Data from Phase 1 Study of BCMAxCD3 Bispecific Teclistamab in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
BioSpace
Mon, 05/18/20 - 10:37 am
JNJ
Janssen
teclistamab
JNJ-7957
clinical trials
ASCO 2020
Multiple Myeloma
Janssen promotes R&D exec into newfound data science role
Fierce Biotech
Wed, 05/6/20 - 12:15 pm
JNJ
Janssen
R&D
data science
Najat Khan
Janssen announces submission of two applications to US FDA seeking approval of SIMPONI ARIA to treat polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis
Pharmaceutical Business Review
Mon, 04/27/20 - 09:29 am
JNJ
Janssen
FDA
Simponi Aria
polyarticular juvenile idiopathic arthritis
juvenile psoriatic arthritis
Janssen's experience illustrates the COVID-19 logistics maze drugmakers must solve: report
Fierce Pharma
Mon, 03/30/20 - 10:27 am
JNJ
Janssen
China
drug manufacturing
‘Drug development is a long, long process’: pharma CEO in Italy sounds a note of caution on Covid-19
Stat
Fri, 03/27/20 - 12:10 am
drug development
COVID-19
Italy
JNJ
Janssen
vaccines
Janssen files MS pill, ahead of FDA decision on BMS’ rival
Pharmaforum
Thu, 03/19/20 - 11:06 am
Janssen
JNJ
multiple sclerosis
MS
FDA
ponesimod
Bristol-Myers Squibb
ozanimod
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »